InvestorsHub Logo
Followers 1
Posts 67
Boards Moderated 0
Alias Born 12/12/2016

Re: None

Wednesday, 01/18/2017 11:07:12 AM

Wednesday, January 18, 2017 11:07:12 AM

Post# of 144814
In response to the PR portion:

"Analysts and shareholders are requested to submit questions they may have about PharmaCyte’s clinical development program via email to investorrelations@pharmacyte.com. Mr. Waggoner will respond to as many of the questions as possible in the time permitted for the call."

I think we should start pondering questions of what exactly we want to know. Consolidate them and submit one questionnaire on behalf of investorhub PMCB board

thoughts?

Oh and please go $PMCB. Daddy needs some god in his grill.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News